Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWH · Entity 7871 | Director · Chief Executive Officer | October 28, 2024 | October 28, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date October 28, 2024 · Filed October 28, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 25,000 |
Reported balance
After 2024-10-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-28 · Grant · Acquired 25,000 · Balance 25,000 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2024 Filed Oct 28, 2024 22:47 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-24-000006 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| July 09, 2024 Filed Jul 9, 2024 21:43 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantWarrant (Right to buy) · Derivative | 13,072 | Not disclosed Strike: $2.25 | Not disclosed |
DisclosureSEC source: 0001849521-24-000005 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,072 Underlying: Common Stock, par value $0.001 · 13,072 shares Expires 2027-07-09 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53. Read SEC document |
| July 09, 2024 Filed Jul 9, 2024 21:43 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 13,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001849521-24-000005 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,668 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 21:30 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon Stock | 9,493 | $2.42 | $22,973.06 |
DisclosureSEC source: 0001849521-24-000004 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,596 F1 · price: The purchase reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.34 to $2.45 per share. The reporting person undertakes to provide to AWH, any security holder of AWH or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| May 13, 2024 Filed May 14, 2024 23:18 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 80,000 | $0.00 Strike: $2.88 | $0.00 |
DisclosureSEC source: 0001849521-24-000003 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-05-13 F1 · derivative.exercise_date: The employee stock option will vest in equal monthly installments over four years beginning June 13, 2024. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 13:54 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee stock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.73 | $0.00 |
DisclosureSEC source: 0001849521-24-000002 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-02-15 F1 · derivative.exercise_date: The employee stock option will vest in three equal annual amounts beginning February 15, 2025. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:31 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseWarrant (Right to Buy) · Derivative | 2,400 | Not disclosed Strike: $4.13 | Not disclosed |
DisclosureSEC source: 0001849521-24-000001 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock, par value $0.001 · 2,400 shares Expires 2029-07-26 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $4.255. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:31 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon Stock | 2,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001849521-24-000001 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,103 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $4.255. Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 22:21 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon Stock | 5,000 | $3.36 | $16,800.00 |
DisclosureSEC source: 0001849521-23-000009 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,703 Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 00:12 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 40,000 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001849521-23-000008 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-11-17 F1 · derivative.exercise_date: The employee stock option will vest in three equal annual amounts beginning November 17, 2024. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 22:35 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-23-047777 · doc4.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-08-29 Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 22:35 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 26,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-047777 · doc4.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,499 F1 · shares: Reflects restricted stock units representing a contingent right to receive one share of common stock. Restricted stock units vested in full immediately upon grant. Read SEC document |
| August 29, 2023 Filed Sep 29, 2023 23:28 UTC Amendment | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001849521-23-000007 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-08-29 Read SEC document |
| August 29, 2023 Filed Sep 29, 2023 23:28 UTC Amendment | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 26,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-23-000007 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,703 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. 100% of the shares vest immediately upon grant. F2 · shares: This amendment is being filed to correct the number of shares on a previously reported grant. Read SEC document |
| July 25, 2023 Filed Jul 26, 2023 22:36 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 26,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-23-000005 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,132 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock. 100% of the shares vest immediately upon grant. Read SEC document |
| July 25, 2023 Filed Sep 29, 2023 23:20 UTC Amendment | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-23-000006 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,236 F1 · shares: This amendment is being filed to reverse a previously reported grant, as well as to correct an error in the number of shares of common stock held, which were over-reported in the original Form 4 filing due to calculation errors. Read SEC document |
| July 24, 2023 Filed Jul 25, 2023 21:16 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon stock | 12,563 | $3.98 | $50,000.74 |
DisclosureSEC source: 0001849521-23-000004 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,665 Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 01:15 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 250,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001849521-23-000003 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: COMMON STOCK · 250,000 shares Expires 2033-02-09 Read SEC document |
| February 09, 2023 Filed Feb 14, 2023 01:15 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 500,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001849521-23-000003 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: COMMON STOCK · 500,000 shares Expires 2033-02-09 F1 · derivative.exercise_date: The employee stock option will vest in three equal annual amounts beginning February 9, 2024. Read SEC document |
| February 01, 2023 Filed Feb 14, 2023 00:50 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001849521-23-000002 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2033-02-01 Read SEC document |
| January 03, 2023 Filed Feb 14, 2023 00:46 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.32 | $0.00 |
DisclosureSEC source: 0001849521-23-000001 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2033-01-03 Read SEC document |
| December 01, 2022 Filed Dec 1, 2022 22:28 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001849521-22-000014 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-12-01 Read SEC document |
| November 01, 2022 Filed Nov 1, 2022 21:00 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001849521-22-000013 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-11-01 Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 22:00 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001849521-22-000012 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-10-03 Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 21:40 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION(RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001849521-22-000011 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-10-03 Read SEC document |
| September 01, 2022 Filed Sep 1, 2022 20:51 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001849521-22-000010 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-09-01 Read SEC document |
| August 25, 2022 Filed Aug 30, 2022 01:28 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseWarrant (Right to buy) · Derivative | 66,667 | Not disclosed Strike: $0.88 | Not disclosed |
DisclosureSEC source: 0001849521-22-000009 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,667 Underlying: Common Stock, par value $0.001 · 66,667 shares Expires 2027-08-25 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit. Read SEC document |
| August 25, 2022 Filed Aug 30, 2022 01:28 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | PurchaseCommon Stock | 66,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001849521-22-000009 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,102 F1 · price: Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit. Read SEC document |
| August 01, 2022 Filed Aug 1, 2022 20:37 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001849521-22-000008 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-08-01 Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:27 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001849521-22-000007 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-07-01 Read SEC document |
| June 01, 2022 Filed Jun 1, 2022 21:26 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001849521-22-000006 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-06-01 Read SEC document |
| May 16, 2022 Filed May 17, 2022 21:02 UTC | Aspira Women's Health Inc. awh · Entity 7871 | PurchaseCommon Stock | 98,000 | $0.76 | $74,891.60 |
DisclosureSEC source: 0001849521-22-000005 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,160 F1 · price: The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.745 to $0.779 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 3, 2022 20:37 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 5,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001849521-22-000004 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: COMMON STOCK · 5,000 shares Expires 2032-05-02 Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:57 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001849521-22-000003 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-04-01 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:30 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001849521-22-000002 · primary_doc.xml · derivative · entry 2 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-31 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 31, 2023. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:30 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantCommon Stock | 23,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-22-000002 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,435 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 21:38 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0001849521-22-000001 · primary_doc.xml · derivative · entry 1 Sandford Nicole · CIK 0001849521 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-03-01 Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 22:12 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 15,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001849521-21-000001 · primary_doc.xml · nonDerivative · entry 1 Sandford Nicole · CIK 0001849521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,402 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.